Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference4%
- Check24 days agoChange DetectedPage version updated to v3.1.0; one term “Early myoclonic encephalopathy” removed.SummaryDifference0.2%
- Check38 days agoChange DetectedCore content updated to Revision: v3.0.2 (replacing v3.0.1). The 'Back to Top' element was removed.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has updated its facility name and location details, specifically replacing the previous mention of Washington, District of Columbia with a more precise address. Additionally, it has introduced new medical terms related to epilepsy, such as Dravet syndrome and early myoclonic encephalopathy.SummaryDifference2%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.